Why Semble’s £30m Series C could reshape private healthcare software in Europe
Find out how Semble’s £30M Series C could reshape connected healthcare software and private clinic workflows across Europe.
Pharma & Biotech
Medical Devices & Diagnostics
GHO Capital and CBC Group deal signals a bigger private capital push into life sciences
GHO Capital and CBC Group are creating a $21bn healthcare investor. Find out what it means for pharma, medtech and life sciences funding.
Pharma & Biotech
Why Knox Lane is taking Cross Country Healthcare private in a $437m all-cash deal
Healthcare staffing is still under pressure. Knox Lane’s $437m Cross Country Healthcare deal turns that reset into a private equity wager.